Anusha Kalbasi
Anusha Kalbasi
1Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
2Parker Institute for Cancer Immunotherapy, San Francisco, CA USA
1,2,✉,#,
Mikko Siurala
Mikko Siurala
2Parker Institute for Cancer Immunotherapy, San Francisco, CA USA
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
2,3,#,
Leon L Su
Leon L Su
4Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA USA
4,#,
Mito Tariveranmoshabad
Mito Tariveranmoshabad
1Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
1,
Lora K Picton
Lora K Picton
4Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA USA
4,
Pranali Ravikumar
Pranali Ravikumar
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Peng Li
Peng Li
5Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD USA
5,
Jian-Xin Lin
Jian-Xin Lin
5Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD USA
5,
Helena Escuin-Ordinas
Helena Escuin-Ordinas
6Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
6,
Tong Da
Tong Da
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Sarah V Kremer
Sarah V Kremer
1Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
1,
Amy L Sun
Amy L Sun
6Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
6,
Sofia Castelli
Sofia Castelli
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Sangya Agarwal
Sangya Agarwal
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
John Scholler
John Scholler
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Decheng Song
Decheng Song
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Philipp C Rommel
Philipp C Rommel
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Enrico Radaelli
Enrico Radaelli
7Penn Vet Comparative Pathology Core, Department of Pathobiology, University of Pennsylvania, Philadelphia, PA USA
7,
Regina M Young
Regina M Young
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
3,
Warren J Leonard
Warren J Leonard
5Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD USA
5,
Antoni Ribas
Antoni Ribas
2Parker Institute for Cancer Immunotherapy, San Francisco, CA USA
6Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
2,6,✉,
Carl H June
Carl H June
2Parker Institute for Cancer Immunotherapy, San Francisco, CA USA
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
2,3,✉,
K Christopher Garcia
K Christopher Garcia
2Parker Institute for Cancer Immunotherapy, San Francisco, CA USA
4Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA USA
8Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA USA
9Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA USA
2,4,8,9,✉
1Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
2Parker Institute for Cancer Immunotherapy, San Francisco, CA USA
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
4Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA USA
5Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD USA
6Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA USA
7Penn Vet Comparative Pathology Core, Department of Pathobiology, University of Pennsylvania, Philadelphia, PA USA
8Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA USA
9Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA USA
Subject terms: Synthetic biology, Immunotherapy, Cancer therapy, Interleukins
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
